3 Reasons Why Growth Investors Shouldn't Overlook New Jersey Resources (NJR)

This is less a “growth stock” story than a duration-and-revisions trade. NJR can outperform the broader utility complex if the market continues to pay for visible cash-flow acceleration and if estimate revisions keep drifting up, but the upside is likely incremental rather than re-rating to a true secular-growth multiple. Relative winners are utilities with clean balance sheets and self-funding capex; relative losers are higher-duration bond-proxy names that rely on yield alone, especially if real rates back up.

The second-order effect is technical: if NJR screens into growth mandates, it can attract incremental ownership from generalist growth and quality baskets, temporarily compressing its yield discount versus peers like WEC, ATO, and SRE. That said, regulated utility economics limit how much operating leverage can actually show through in one year; the real catalyst path is 1-3 months of estimate revisions into earnings, then 6-18 months of rate-case execution, weather normalization, and capital deployment. A warm winter, delayed rate recovery, or a sustained rise in Treasury yields would quickly expose how fragile the rerating case is.

The contrarian read is that the market often overpays for “growth” labeling in low-beta sectors when the underlying EPS deltas are modest. NJR looks more like a defensive compounder with a better-than-average near-term setup than a structural compounder with durable above-peer growth, so the thesis is more about relative performance than absolute upside. If revisions stall or the stock fails to hold a premium to XLU after the next print, the move has probably been fully priced in.